ORBIMED ADVISORS LLC
Top Portfolio Positions
106 positions ·
$5,343,151,020 total
· as of Mar 31, 2026
| Ticker | Company | Shares | Value (USD) | % of Portfolio | Open |
|---|---|---|---|---|---|
| MYGN |
Myriad Genetics Inc
Healthcare
|
125,000,000 | $562,500,000 | 10.53% | |
| EWTX |
Edgewise Therapeutics, Inc.
Healthcare
|
15,518,492 | $488,832,498 | 9.15% | |
| ELVN |
Enliven Therapeutics, Inc.
Healthcare
|
7,959,538 | $312,013,889 | 5.84% | |
| RCEL |
AVITA Medical, Inc.
Healthcare
|
82,010,995 | $303,440,681 | 5.68% | |
| MDXH |
MDxHealth SA
Healthcare
|
124,306,000 | $285,903,800 | 5.35% | |
| LLY |
ELI LILLY & Co
Healthcare
|
236,800 | $217,801,536 | 4.08% | |
| BSX |
Boston Scientific Corp
Healthcare
|
2,382,100 | $149,476,775 | 2.80% | |
| SION |
Sionna Therapeutics, Inc.
Healthcare
|
3,530,702 | $141,545,843 | 2.65% | |
| AZN |
Astrazeneca PLC
Healthcare
|
670,200 | $132,176,844 | 2.47% | |
| MBX |
MBX Biosciences, Inc.
Healthcare
|
3,637,887 | $108,590,926 | 2.03% |
Portfolio Trend
25 quarters · across all stocks
Holdings in URGN
Shares Held
Position Value (USD)
4 quarters on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $15,741,256 | 875,487 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $20,503,905 | 875,487 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $13,745,550 | 689,000 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $6,554,080 | 478,400 | Shares | Sole | 2025-08-14 | |
| No 13F history on record for this holder in this stock. | ||||||